{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:57Z","timestamp":1792784397637,"version":"4.5.0"},"reference-count":207,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Jordi Bover belongs to the Spanish National Network of Kidney Research RedinRen","award":["RD06\/0016\/0001"],"award-info":[{"award-number":["RD06\/0016\/0001"]}]},{"name":"Jordi Bover belongs to the Spanish National Network of Kidney Research RedinRen","award":["RD12\/0021\/0033"],"award-info":[{"award-number":["RD12\/0021\/0033"]}]},{"name":"Spanish National Biobank network","award":["RD09\/0076\/00064"],"award-info":[{"award-number":["RD09\/0076\/00064"]}]},{"name":"Catalan Nephrology Research Group AGAUR","award":["2009 SGR-1116"],"award-info":[{"award-number":["2009 SGR-1116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.semnephrol.2014.09.008","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T16:46:24Z","timestamp":1418834784000},"page":"626-640","source":"Crossref","is-referenced-by-count":124,"title":["Adynamic Bone Disease: From Bone to Vessels in Chronic Kidney Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Jordi","family":"Bover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo J.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.09.008_bib1","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00005792-194305000-00002","article-title":"Studies in calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (A.T. 10) and iron","volume":"22","author":"Lui","year":"1943","journal-title":"Medicine"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2014.09.008_bib4","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","article-title":"Histomorphometric measurements of bone turnover, mineralization, and volume","volume":"3","author":"Ott","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gft514","article-title":"Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?","author":"Cozzolino","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib6","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfq513","article-title":"Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a European Renal Best Practice (ERBP) commentary statement","volume":"25","author":"Goldsmith","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(02)37965-0","article-title":"Form of late rickets associated with albuminuria, rickets of adolescents","volume":"1","author":"Lucas","year":"1883","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib8","first-page":"87","article-title":"Tumor of the parathyroid gland","volume":"16","author":"MacCallum","year":"1905","journal-title":"John Hopkins Hosp Bull"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/adc.8.46.265","article-title":"Renal rickets associated with parathyroid hyperplasia","volume":"8","author":"Langmead","year":"1933","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib10","series-title":"The kidney","first-page":"2103","article-title":"Renal osteodystrophies","author":"Llach","year":"2000"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/8756-3282(92)90354-Y","article-title":"Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?","volume":"13","author":"Cohen-Solal","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib12","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1755.1998.00080.x","article-title":"Hypokinetic azotemic osteodystrophy","volume":"54","author":"Cannata-Andia","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","article-title":"Osteoporosis and adynamic bone in chronic kidney disease","volume":"26","author":"Cannata-Andia","year":"2013","journal-title":"J Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2014.09.008_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/11.supp3.29","article-title":"The aplastic form of renal osteodystrophy","volume":"11","author":"Sherrard","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib15","first-page":"135","article-title":"Adynamic bone disease-bone and beyond","volume":"3","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MNH.0b013e32832c4df0","article-title":"Adynamic bone disease: clinical and therapeutic implications","volume":"18","author":"Frazao","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: the role of \u201csuppressed\u201d parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.ajkd.2006.05.028","article-title":"Variant of adynamic bone disease in hemodialysis patients: fact or fiction?","volume":"48","author":"Rocha","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","article-title":"When, how, and why a bone biopsy should be performed in patients with chronic kidney disease (CKD)?","volume":"34","author":"Urena","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ki.2008.60","article-title":"Adynamic bone in patients with chronic kidney disease","volume":"73","author":"Andress","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ndt\/gfq491","article-title":"The link between bone and coronary calcifications in CKD-5 patients on haemodialysis","volume":"26","author":"Asci","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib24","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5414\/CNP62432","article-title":"High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis","volume":"62","author":"Lobao","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure--an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.008_bib26","first-page":"21","article-title":"Low turn-over bone disease in patients with chronic renal disease","volume":"60","author":"Spasovski","year":"2007","journal-title":"Med Pregl"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib28","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.09.008_bib29","doi-asserted-by":"crossref","first-page":"i9","DOI":"10.1093\/ndt\/gfh1002","article-title":"The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?","volume":"19","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1359\/jbmr.090735","article-title":"Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment","volume":"25","author":"Tomiyama","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib32","first-page":"1019","article-title":"Kidney and bone update: the 5-year history and future of CKD-MBD. Bone biopsy and histomorphometrical analysis","volume":"22","author":"Tsukamoto","year":"2012","journal-title":"Clin Calcium"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12018-011-9114-6","article-title":"Specific bone and mineral disorders in patients with cronic kidney disease","volume":"10","author":"Morrow","year":"2012","journal-title":"Clin Ref Bone Miner Metab"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/00000441-200008000-00002","article-title":"Different patterns of renal osteodystrophy in Iberoamerica","volume":"320","author":"Jorgetti","year":"2000","journal-title":"Am J Med Sci"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2014.09.008_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib36","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2215\/CJN.01770408","article-title":"Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients","volume":"4","author":"Moore","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/ndt\/9.5.517","article-title":"Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis","volume":"9","author":"Hernandez","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib38","first-page":"295","article-title":"Strategies to manage low-bone turnover","volume":"29","author":"Spasovski","year":"2009","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/kisup.2011.28","article-title":"Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation","volume":"1","author":"Bover","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib40","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ki.1994.276","article-title":"The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia","volume":"46","author":"Bover","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/archinte.1973.00320120068006","article-title":"Excretion of phosphate and calcium. Physiology of their renal handling and relation to clinical medicine","volume":"131","author":"Massry","year":"1973","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S8756-3282(99)00169-6","article-title":"Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus","volume":"25","author":"Bover","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib43","first-page":"117","article-title":"Adynamic bone disease: an update and overview","volume":"18","author":"Coen","year":"2005","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib45","first-page":"311","article-title":"[Renal bone disease and osteoprotegerin]","volume":"13","author":"Kazama","year":"2003","journal-title":"Clin Calcium"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib46","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/ki.1993.377","article-title":"Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism","volume":"44","author":"Reichel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib47","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ki.1994.79","article-title":"The renal PTH\/PTHrP receptor is down-regulated in rats with chronic renal failure","volume":"45","author":"Urena","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib49","first-page":"E654","article-title":"Downregulation of the PTH\/PTHrP receptor by vitamin D3 in the osteoblast-like ROS 17\/2.8 cells","volume":"270","author":"Xie","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CNP57051","article-title":"Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism","volume":"57","author":"Sawaya","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib51","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ki.1994.129","article-title":"Factors in the development of secondary hyperparathyroidism during graded renal failure in the rat","volume":"45","author":"Bover","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib53","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ki.2012.453","article-title":"Report on 2012 ISN Nexus symposium: \u2018bone and the kidney\u2019","volume":"83","author":"Drueke","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.008_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2006.01663.x","article-title":"Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease","volume":"36","author":"Mathew","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib56","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib57","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ki.1989.219","article-title":"Plasma insulin-like growth factors and bone formation in uremic hyperparathyroidism","volume":"36","author":"Andress","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1053\/j.ajkd.2008.06.024","article-title":"Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study","volume":"52","author":"Barreto","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ndt\/gft275","article-title":"Can we use circulating biomarkers to monitor bone turnover in CKD haemodialysis patients? Hypotheses and facts","volume":"29","author":"Delanaye","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jbspin.2012.09.014","article-title":"Pathophysiology of chronic kidney disease-mineral and bone disorder","volume":"79","author":"Mac","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib61","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib62","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ki.1991.118","article-title":"Identification of a low molecular weight inhibitor of osteoblast mitogenesis in uremic plasma","volume":"39","author":"Andress","year":"1991","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib63","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1681\/ASN.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ASN.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib65","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1359\/jbmr.2003.18.6.960","article-title":"High bone mass in mice expressing a mutant LRP5 gene","volume":"18","author":"Babij","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib66","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib67","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib68","doi-asserted-by":"crossref","first-page":"e79721","DOI":"10.1371\/journal.pone.0079721","article-title":"Effects of dietary phosphate on adynamic bone disease in rats with chronic kidney disease--role of sclerostin?","volume":"8","author":"Ferreira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib69","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","article-title":"Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease","volume":"45","author":"Pereira","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib70","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","article-title":"The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment","volume":"26","author":"Lu","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib71","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jbmr.2044","article-title":"The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b","volume":"29","author":"Li","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib75","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib77","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness","volume":"90","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib78","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women","volume":"26","author":"Ardawi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib79","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2215\/CJN.01370211","article-title":"Sclerostin: just one more player in renal bone disease?","volume":"6","author":"Drueke","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib80","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/ndt\/gft222","article-title":"Sclerostin in CKD-MBD: one more paradoxical bone protein?","volume":"28","author":"Jean","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib83","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/ndt\/gft039","article-title":"Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?","volume":"28","author":"Viaene","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.semnephrol.2014.10.002","article-title":"The uses and abuses of vitamin D compounds in chronic kidney disease-mineral bone disease (CKD-MBD)","volume":"34","author":"Goldsmith","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1359\/jbmr.061009","article-title":"High dietary phosphate intake reduces bone strength in the growing rat skeleton","volume":"22","author":"Huttunen","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib86","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/gfs333","article-title":"High phosphate feeding promotes mineral and bone abnormalities in mice with chronic kidney disease","volume":"28","author":"Lau","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib87","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1681\/ASN.2006050490","article-title":"Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy","volume":"18","author":"Mathew","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib88","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib90","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/ki.1995.241","article-title":"Development of secondary hyperparathyroidism and bone disease in diabetic rats with renal failure","volume":"47","author":"Jara","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib91","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bone.2009.07.016","article-title":"The impact of diabetes mellitus on vitamin D metabolism in predialysis patients","volume":"45","author":"Tanaka","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib92","doi-asserted-by":"crossref","first-page":"E1901","DOI":"10.1210\/jc.2013-2418","article-title":"Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease","volume":"98","author":"Muras","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.09.008_bib93","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1053\/ajkd.2001.27428","article-title":"Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy","volume":"38","author":"Yamamoto","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib94","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib95","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib96","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1359\/jbmr.090501","article-title":"Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study","volume":"24","author":"Freedman","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib97","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000337832","article-title":"Role of vitamin D receptor activators in peritoneal dialysis","volume":"178","author":"Bover","year":"2012","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib98","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/ajkd.2000.19093","article-title":"Parathormone secretion in peritoneal dialysis patients with adynamic bone disease","volume":"36","author":"S\u00e1nchez-M","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib99","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/ndt\/12.10.2144","article-title":"High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population","volume":"12","author":"Couttenye","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.jrn.2009.10.006","article-title":"Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients","volume":"20","author":"Dukkipati","year":"2010","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib101","first-page":"35","article-title":"Online hemodiafiltration in children and hypoparathyroidism: a single-centre series of cases","volume":"10","author":"Perouse de","year":"2014","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib102","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1093\/ndt\/gfm931","article-title":"Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K\/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients","volume":"23","author":"Mazzaferro","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib103","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1046\/j.1442-2042.2001.00340.x","article-title":"Development of low-turnover bone diseases after parathyroidectomy and autotransplantation","volume":"8","author":"Yajima","year":"2001","journal-title":"Int J Urol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ckj\/sft028","article-title":"Utilization of parathyroidectomy for secondary hyperparathyroidism in end stage renal disease","volume":"6","author":"Konstantinidis","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib105","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib106","first-page":"192","article-title":"Long-term outcome following total parathyroidectomy in patients with end-stage renal disease","volume":"39","author":"Kaye","year":"1993","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib107","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1523-1755.61.s80.27.x","article-title":"Parathyroidectomy in dialysis patients","volume":"80","author":"de Francisco","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib108","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1046\/j.1523-1755.63.s85.23.x","article-title":"Parathyroidectomy: whom and when?","volume":"85","author":"Jofre","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib109","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ki.2013.254","article-title":"Recent advances in the noninvasive diagnosis of renal osteodystrophy","volume":"84","author":"Moorthi","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib110","unstructured":"Brandenburg V, Kr\u00fcger T. Special issues in renal osteodystrophy, ROD: survey results. 2014. Available: http:\/\/ndt-educational.org\/rod.html. Accessed: April 30, 2014."},{"issue":"5","key":"10.1016\/j.semnephrol.2014.09.008_bib111","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00198-012-2133-4","article-title":"Alterations of bone microstructure and strength in end-stage renal failure","volume":"24","author":"Trombetti","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib112","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2009.374","article-title":"Parathyroid hormone measurement in CKD","volume":"77","author":"Souberbielle","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib114","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib115","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.1523-1755.1999.00461.x","article-title":"Circulating biochemical markers of bone remodeling in uremic patients","volume":"55","author":"Urena","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib116","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.ndt.a027457","article-title":"Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib117","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib118","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5414\/CNP70296","article-title":"Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3-5","volume":"70","author":"Lehmann","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib119","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1-84)\/large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5414\/CNP71267","article-title":"Absence of adynamic bone disease in African-Americans with CKD stage 5 after 3 years of vitamin D therapy guided by iPTH and the PTH-(1-84)\/N-terminally truncated PTH fragments ratio","volume":"71","author":"Fehmi","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib122","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2009.12.041","article-title":"Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study","volume":"55","author":"Herberth","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib123","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2215\/CJN.10331012","article-title":"Rebuttal: PTH--a particularly tricky hormone: why measure it at all in kidney patients?","volume":"8","author":"Sprague","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib124","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.09580911","article-title":"PTH--a particularly tricky hormone: why measure it at all in kidney patients?","volume":"8","author":"Garrett","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib126","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.semnephrol.2014.09.006","article-title":"News on biomarkers in CKD-MBD","volume":"34","author":"Mazzaferro","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib127","first-page":"209","article-title":"Sociedade Brasileira de Nefrologia. Adynamic bone disease","volume":"33","author":"de Oliveira","year":"2011","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.1995.292","article-title":"The pathogenesis of parathyroid gland hyperplasia in chronic renal failure","volume":"48","author":"Drueke","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib129","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5301\/jn.5000187","article-title":"Bone-vascular cross-talk","volume":"25","author":"London","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib132","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib133","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib134","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib135","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib136","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study","volume":"26","author":"Naves-Diaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib137","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib138","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib139","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib140","doi-asserted-by":"crossref","first-page":"c204","DOI":"10.1159\/000321507","article-title":"Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study","volume":"118","author":"Jean","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib141","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1525-139X.2010.00823.x","article-title":"Target levels for serum phosphorus and parathyroid hormone","volume":"24","author":"Qunibi","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib142","unstructured":"Qunibi WY, Henrich WL. Adynamic bone disease associated with chronic kidney disease. Available: http:\/\/www.uptodate.com\/contents\/adynamic-bone-disease-associated-with-chronic-kidney-disease?source=search_result&search=adynamic+bone&selectedTitle=1~25. Accessed: April 30, 2014."},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.09.008_bib143","article-title":"Spanish Nephrology Society. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.)","volume":"31","author":"Torregrosa","year":"2011","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib144","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","article-title":"Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients","volume":"12","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","article-title":"Risk factors for vertebral fractures in renal osteodystrophy","volume":"33","author":"Atsumi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib146","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib147","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib148","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.ackd.2013.06.007","article-title":"Women and CKD-mineral and bone disorder","volume":"20","author":"Ho","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib149","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00223-001-1041-y","article-title":"Therapy of male osteoporosis with parathyroid hormone","volume":"69","author":"Bilezikian","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib151","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jcem.84.2.5498","article-title":"Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone","volume":"84","author":"Duan","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib152","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11926-012-0243-9","article-title":"Bone and kidney disease: diagnostic and therapeutic implications","volume":"14","author":"Jamal","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib153","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib154","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1755.2003.00837.x","article-title":"Total hip bone mass predicts survival in chronic hemodialysis patients","volume":"63","author":"Taal","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib155","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib156","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib157","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10157-011-0577-z","article-title":"Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients","volume":"16","author":"Rhee","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib158","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib159","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib160","first-page":"423","article-title":"The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification","volume":"74","author":"London","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib161","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MNH.0b013e328362155b","article-title":"Vascular calcification","volume":"22","author":"Massy","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib162","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2215\/CJN.01870408","article-title":"Low bone volume--a risk factor for coronary calcifications in hemodialysis patients","volume":"4","author":"Adragao","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib163","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfm370","article-title":"Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?","volume":"22","author":"Coen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib164","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000151769","article-title":"Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study","volume":"29","author":"Coen","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib165","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2006.02.040","article-title":"Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation","volume":"47","author":"Caira","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib166","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib167","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib168","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1016\/j.semnephrol.2014.09.008_bib169","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2215\/CJN.02500607","article-title":"Effects of treatment of renal osteodystrophy on bone histology","volume":"3","author":"Malluche","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2169\/internalmedicine.46.6338","article-title":"Effect of sevelamer hydrochloride on markers of bone turnover in Japanese dialysis patients with low biointact PTH levels","volume":"46","author":"Iwata","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib171","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1744-9987.2010.00898.x","article-title":"Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia","volume":"15","author":"Shigematsu","year":"2011","journal-title":"Ther Apher Dial"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2014.09.008_bib172","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1744-9987.12038","article-title":"Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease","volume":"17","author":"Yajima","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib173","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib174","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib175","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib176","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1542-4758.2011.00575.x","article-title":"Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study","volume":"15","author":"Jean","year":"2011","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib177","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib178","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib179","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib180","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/ndt\/gfs108","article-title":"VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH <\/= 150 pg\/mL: results of the Italian FARO Survey","volume":"27","author":"Cozzolino","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib181","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1525-139X.2011.00986.x","article-title":"Vitamin d and stage 5 chronic kidney disease: a new paradigm?","volume":"25","author":"Heaf","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib182","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.jrn.2006.07.006","article-title":"Impact of kidney bone disease and its management on survival of patients on dialysis","volume":"17","author":"Lee","year":"2007","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib183","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib184","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.V11101857","article-title":"1,25-Dihydroxy-19-nor-vitamin D(2), a vitamin D analog with reduced bone resorbing activity in vitro","volume":"11","author":"Holliday","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jsbmb.2006.07.004","article-title":"Differential effects of Vitamin D analogs on calcium transport","volume":"103","author":"Nakane","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib186","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2215\/CJN.03461006","article-title":"Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)\/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease","volume":"2","author":"Monier-Faugere","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib187","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","article-title":"Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series","volume":"29","author":"Amerling","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib188","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ki.2012.253","article-title":"Bisphosphonate safety and efficacy in chronic kidney disease","volume":"82","author":"Ott","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib189","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrneph.2013.182","article-title":"Therapy for patients with CKD and low bone mineral density","volume":"9","author":"Ott","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib190","first-page":"329","article-title":"Successful treatment of calcific uraemic arteriolopathy with bisphosphonates","volume":"32","author":"Torregrosa","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib191","doi-asserted-by":"crossref","DOI":"10.5414\/CN107923","article-title":"Clinical management of calcific uremic arteriolopathy before and after therapeutic inclusion of bisphosphonates","author":"Torregrosa","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib192","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/ndt\/gfh305","article-title":"Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure","volume":"19","author":"Monney","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib193","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00223-002-1006-9","article-title":"The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption","volume":"71","author":"Price","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib194","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.ajkd.2006.04.062","article-title":"Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium","volume":"48","author":"Shiraishi","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1677\/jme.0.0290015","article-title":"The search for calcium receptor antagonists (calcilytics)","volume":"29","author":"Nemeth","year":"2002","journal-title":"J Mol Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.008_bib196","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1177\/089686080902902S02","article-title":"The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients","volume":"29","author":"Demirci","year":"2009","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib197","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/0886022X.2013.832309","article-title":"Association of dialysate calcium concentration with fetuin a level and carotid intima-media thickness in peritoneal dialysis patients","volume":"36","author":"Liang","year":"2014","journal-title":"Ren Fail"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib198","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5414\/CNP67020","article-title":"Low-calcium dialysate improves mineral metabolism in hemodialysis patients","volume":"67","author":"Fujimori","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib199","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1744-9987.2007.00419.x","article-title":"Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study","volume":"11","author":"Lezaic","year":"2007","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib200","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bone.2007.06.014","article-title":"Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium","volume":"41","author":"Spasovski","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib201","article-title":"Reduction of calcium exposure slows down progression of vascular calcification and improves adynamic bone disease [abstract]","volume":"3","author":"Ok","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH(1-34)): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1525-139X.2010.00817.x","article-title":"Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues?","volume":"24","author":"Jamal","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib204","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/thy.2005.15.1299","article-title":"Definitive treatment for persistent hypoparathyroidism in a kidney transplant patient: parathyroid allotransplantation","volume":"15","author":"Torregrosa","year":"2005","journal-title":"Thyroid"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2014.09.008_bib205","first-page":"109","article-title":"[New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics]","volume":"25","author":"Bover","year":"2005","journal-title":"Nefrologia"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ckj\/sfs148","article-title":"Recombinant PTH associated with hypercalcaemia and renal failure","volume":"6","author":"Ayasreh","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.semnephrol.2014.09.008_bib207","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/BOR.0000000000000057","article-title":"Established and forthcoming drugs for the treatment of osteoporosis","volume":"26","author":"Lems","year":"2014","journal-title":"Curr Opin Rheumatol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951400148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027092951400148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T11:01:10Z","timestamp":1650798070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027092951400148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":207,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S027092951400148X"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.09.008","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}